We are live on ! Find out more
SQZ

SQZ Biotechnologies Company
SQZ

Delisted

SQZ was delisted on the 3rd of July, 2023.

Back to rankings

49 hedge funds and large institutions have $159M invested in SQZ Biotechnologies Company in 2021 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 26 increasing their positions, 7 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

271% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 7

28% more capital invested

Capital invested by funds: $125M → $159M (+$34.7M)

22% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 9

4% more funds holding

Funds holding: 47 → 49 (+2)

Holders
49
Holders Change
+2
Holders Change %
+4.26%
% of All Funds
0.85%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
26
Reduced
7
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$12.9M
2
6CM
683 Capital Management
New York
+$10.3M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$6.81M
4
State Street
State Street
Massachusetts
+$2.85M
5
JP Morgan Chase
JP Morgan Chase
New York
+$2.18M

Top Sellers

Rank Fund Capital Flow
1
BM
Bridger Management
New York
-$9.96M
2
AI
Alphabet Inc
California
-$9.5M
3
CCM
CAAS Capital Management
New York
-$1.8M
4
LM
Luminus Management
Texas
-$1.52M
5
Tudor Investment Corp
Tudor Investment Corp
Connecticut
-$711K
Name Holding Trade Value Shares
Change 		Change in
Stake
Temasek Holdings
1
Temasek Holdings
Singapore
$36.6M +$265K +20,252 +0.8%
AG
2
Artal Group
Luxembourg
$23.2M – – –
6CM
3
683 Capital Management
New York
$19.9M +$10.3M +787,193 +134%
BlackRock
4
BlackRock
New York
$17.6M +$12.9M +983,747 +424%
MC
5
Maverick Capital
Texas
$14.2M +$304K +23,264 +2%
Vanguard Group
6
Vanguard Group
Pennsylvania
$12.9M +$6.81M +520,995 +141%
LM
7
Luminus Management
Texas
$5.11M -$1.52M -116,112 -25%
State Street
8
State Street
Massachusetts
$4.13M +$2.85M +218,007 +321%
Geode Capital Management
9
Geode Capital Management
Massachusetts
$3.54M +$2.04M +155,902 +175%
Northern Trust
10
Northern Trust
Illinois
$2.65M +$1.56M +119,662 +187%
JP Morgan Chase
11
JP Morgan Chase
New York
$2.63M +$2.18M +166,879 +1,102%
Morgan Stanley
12
Morgan Stanley
New York
$2.37M +$2.12M +162,401 +8,741%
AI
13
Alphabet Inc
California
$1.5M -$9.5M -727,460 -87%
N
14
Nuveen
North Carolina
$1.23M +$1.11M +85,179 New
Charles Schwab
15
Charles Schwab
California
$1.21M +$494K +37,832 +83%
Deutsche Bank
16
Deutsche Bank
Germany
$1.2M +$1.04M +79,943 +2,807%
BP
17
BBR Partners
New York
$1.06M +$961K +73,599 New
Jacobs Levy Equity Management
18
Jacobs Levy Equity Management
New Jersey
$1M +$590K +45,159 +188%
Bank of New York Mellon
19
Bank of New York Mellon
New York
$881K +$624K +47,792 +361%
WP
20
Woodline Partners
California
$747K – – –
Acadian Asset Management
21
Acadian Asset Management
Massachusetts
$668K +$604K +46,249 New
SG Americas Securities
22
SG Americas Securities
New York
$615K +$27.1K +2,078 +5%
Bank of America
23
Bank of America
North Carolina
$494K +$73.2K +5,606 +20%
Goldman Sachs
24
Goldman Sachs
New York
$491K +$112K +8,545 +34%
Two Sigma Investments
25
Two Sigma Investments
New York
$466K -$143K -10,922 -25%
1
2 3

SQZ Hedge Fund Activity: Q2 2021 in Review

49 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in SQZ Biotechnologies Company (SQZ) for Q2 2021, worth a combined $159M — up 28% from $125M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new SQZ positions and 9 closed out — a net gain of 2 holders — while 26 added to existing stakes and 7 trimmed.

The largest buyer was BlackRock, adding an estimated $12.9M. The largest seller was Bridger Management, exiting entirely with an estimated $9.96M sold.

  • 49 institutional investors held SQZ Biotechnologies Company (SQZ) as of Q2 2021, up from 47 in Q1 2021.
  • Funds reported $159M of SQZ Biotechnologies Company stock for Q2 2021, up 28% quarter-over-quarter.
  • 11 funds opened new SQZ Biotechnologies Company positions in Q2 2021 and 9 closed out, a net change of +2 holders.
  • The largest SQZ Biotechnologies Company buyer in Q2 2021 was BlackRock, an estimated $12.9M added.
  • The largest SQZ Biotechnologies Company seller in Q2 2021 was Bridger Management, an estimated $9.96M sold.

Based on aggregated 13F filings for Q2 2021.